TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Atlas Antibodies AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
159,671
|
156,596
|
146,076 |
Financial expenses |
24,474
|
10,230
|
4,626 |
Earnings before taxes |
50,654
|
82,275
|
57,702 |
EBITDA |
58,721
|
51,952
|
128,155 |
Total assets |
2,945,579
|
2,907,393
|
2,837,400 |
Current assets |
302,306
|
254,884
|
171,815 |
Current liabilities |
15,391
|
20,874
|
19,088 |
Equity capital |
2,417,593
|
2,377,653
|
2,314,847 |
- share capital |
489
![]() |
489
![]() |
489 |
Employees (average) |
70
|
82
|
79 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
82.1%
|
81.8%
|
81.6% |
Turnover per employee |
2,281
|
1,910
|
1,849 |
Profit as a percentage of turnover |
31.7%
|
52.5%
|
39.5% |
Return on assets (ROA) |
2.6%
|
3.2%
|
2.2% |
Current ratio |
1964.2%
|
1221.1%
|
900.1% |
Return on equity (ROE) |
2.1%
|
3.5%
|
2.5% |
Change turnover |
3,075
|
10,520
|
18,502 |
Change turnover % |
2%
|
7%
|
15% |
Chg. No. of employees |
-12
|
3
|
13 |
Chg. No. of employees % |
-15%
|
4%
|
20% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.